HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
S G Cho Selected Research
S G Cho Research Topics
Disease
2
Aplastic Anemia (Anemia, Hypoplastic)
11/2016 - 10/2010
1
Necrotizing Fasciitis
06/2017
1
Atrial Fibrillation
06/2017
1
Wounds and Injuries (Trauma)
06/2017
1
Hepatitis B
06/2017
1
Delayed Graft Function
06/2017
1
Hypertension (High Blood Pressure)
04/2016
1
Fever (Fevers)
04/2016
1
Abscess
04/2016
1
Renal Insufficiency (Renal Failure)
04/2016
1
Back Pain (Backache)
04/2016
1
Suppuration
04/2016
1
Pyuria
04/2016
1
Dehydration (Water Stress)
08/2015
1
Atopic Dermatitis (Atopic Eczema)
08/2015
1
Leukemia
12/2008
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2008
1
Carcinoma (Carcinomatosis)
05/2008
1
Infectious Arthritis (Septic Arthritis)
05/2008
1
Infections
07/2006
1
Graft vs Host Disease (Graft-Versus-Host Disease)
07/2006
1
Chronic Hepatitis (Chronic Active Hepatitis)
12/2001
1
Fibrosis (Cirrhosis)
12/2001
1
Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
11/2001
1
Neoplasms (Cancer)
05/2000
1
Retinoblastoma (Glioblastoma, Retinal)
05/2000
Drug/Important Bio-Agent (IBA)
1
Meropenem (Merrem)
FDA Link
Generic
06/2017
1
fludarabine
IBA
11/2016
1
Carbapenems (Carbapenem Antibiotics)
IBA
04/2016
1
Irritants (Vesicants)
IBA
08/2015
1
Imatinib Mesylate (Gleevec)
FDA Link
12/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2006
1
Lipids
IBA
12/2001
1
Protons (Proton)
IBA
12/2001
1
Hydrogen
IBA
12/2001
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2001
1
Retinoblastoma Protein
IBA
05/2000
Therapy/Procedure
2
Kidney Transplantation
06/2017 - 04/2016
2
Stem Cell Transplantation
11/2016 - 07/2006
1
Peritoneal Dialysis
06/2017
1
Nephrectomy
04/2016
1
Oral Administration
08/2015
1
Transplantation
10/2010
1
Therapeutics
12/2008
1
Radiotherapy
05/2008
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2001